Renasolve, Inc. is a physician-led healthcare company that is reshaping kidney care in rural and underserved populations. Founded by Dr. Rubin Chandran, a board-certified nephrologist with over 20 years of clinical leadership, Renasolve addresses the critical gap in nephrology access in small and mid-sized hospitals across the U.S.
Currently operating in Oklahoma, Oregon, Washington, Wyoming, North Carolina, North Dakota and Idaho, with more expansions in progress, Renasolve partners with hospitals to deliver comprehensive, cost-effective nephrology and dialysis solutions tailored to local community needs.
Dedicated, board-certified nephrologists available via telehealth and on-site rotations, ensuring continuous, high-quality inpatient care across partner hospitals.
Renasolve provides, staffs, and manages in-house dialysis services without upfront capital costs, enabling hospitals to create new revenue streams and enhance patient outcomes.
Strategic guidance and program development for outpatient dialysis and apheresis centers, optimizing local access and clinical efficiency in underserved areas.
Unlike telehealth-only providers, Renasolve combines expert nephrology care with complete dialysis unit buildouts, ensuring seamless patient care and minimizing operational disruptions for partner hospitals.
All dialysis infrastructure is provided by Renasolve, allowing hospitals to quickly implement high-quality nephrology services with no upfront investment.
Each partner hospital receives a dedicated team of 2–3 nephrologists, fostering strong relationships, ensuring consistency of care, and minimizing fragmentation across departments.
Partner hospitals experience measurable improvements, including:
Dr. Rubin Chandran, Founder & CEO, brings unmatched expertise in nephrology operations, having successfully launched numerous inpatient and outpatient dialysis programs nationwide. His leadership ensures Renasolve’s vision is rooted in clinical excellence and operational success.
With a scalable model, proven clinical outcomes, and growing market demand, Renasolve is poised for significant expansion. Investors now have a unique opportunity to support a company at the forefront of rural kidney care innovation—driving better patient outcomes, expanding access to care, and generating long-term returns.